FDA Relaxes RU-486 Guidelines Endangers Women

Salem, OR—On Wednesday, in response to a request by the U.S. distributor of RU-486, the Food and Drug Administration released new guidelines for “the abortion pill.” They modified dosages, changed the administration, reduced the number of office visits, expanded the prescriber pool, and extended the time frame when the drugs may be used. Though this […]